EvlaBio is a biotech company, focused on the development of a therapy addressing a high unmet medical need in the cardiorenal space.
Specifically, we are addressing Left Ventricular Hypertrophy (LVH) in the setting of chronic kidney disease, which affects millions of patients and for which there are limited treatment options.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Zurich, Ch
- Industry
- Biotechnology
- Website
- http://www.evlabio.com
- HQ
- Zurich
Evlabio Questions
Evlabio's website is http://www.evlabio.com
Evlabio's LinkedIn profile is https://ch.linkedin.com/company/evlabio
Evlabio has
7 employees.
View email and phone details for 7
employees at Evlabio.
Evlabio's industry is
Biotechnology
Evlabio's top competitors are
Comphya,
Ka-Ex®,
Nuclidium Ag,
Adbio Partners,
4dcell,
Askearth,
Creal,
Jaipur Robotics,
Umami,
Tissue Dynamics.
Evlabio's categories are Biotechnology
Evlabio's founding year is 2022
